Crossmark

Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?

Published Online: 2025-04-03

Authors

Górecki, Dariusz C. https://orcid.org/0000-0003-3584-1654
Kalinski, Pawel

Pomeroy, Joanna
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 10 December 2024

Revised: 21 March 2025

Accepted: 25 March 2025

First Online: 3 April 2025

Competing interests

: The authors declare no competing interests.

Document is current